CROmed

Budapest, Hungary Founded: 2010 • Age: 16 yrs
Specialized imaging services for preclinical and clinical research are provided.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About CROmed

CROmed is a company based in Budapest (Hungary) founded in 2010. CROmed operates in a competitive market with competitors including BioTelemetry, Oncodesign Services, Calyx, Quantificare and Molecular NeuroImaging, among others.

  • Headquarter Budapest, Hungary
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $273.89 K (USD), Grant

    Sep 01, 2020

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CROmed

Investors in CROmed

CROmed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for CROmed

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CROmed

Investments
Premium access

Investment portfolio details for CROmed

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CROmed

Premium access

Detailed financials for CROmed

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cromed Comparisons

CROmed Primary company
Description
Specialized imaging services for preclinical and clinical re...
Location
Budapest, Hungary
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for CROmed

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CROmed

CROmed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioTelemetry, Oncodesign Services, Calyx, Quantificare and Molecular NeuroImaging, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Wireless products for monitoring health parameters are offered.
Locked Locked Locked
CRO focused on oncology drugs discovery, bioanalysis, and preclinical services
Locked Locked Locked
CRO providing imaging services for clinical development
Locked Locked Locked
Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications
Locked Locked Locked
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
Locked Locked Locked
Offers medical imaging expertise for oncology research and clinical trials globally.
Premium access

Detailed competitors of CROmed

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cromed

Premium access

Complete news archive for CROmed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CROmed

CROmed was founded in 2010 and raised its 1st funding round 10 years after it was founded.

CROmed is headquartered in Budapest, Hungary.

Domokos Mathe is the current CEO of CROmed.

CROmed was founded in 2010 in Budapest, Hungary, as a contract research organization focused on molecular imaging. Services utilizing SPECT, CT, PET, and MRI techniques are delivered for preclinical discovery through phase II clinical trials. Imaging centers operate in Budapest, Stockholm, and Debrecen to address dosimetry, biodistribution, and biomarker challenges in oncology, CNS, inflammation, cardiovascular, and regenerative medicine areas. Distribution of VetEquip and Starr Life Sciences products is also handled.

CROmed's top competitors include BioTelemetry, Oncodesign Services and Calyx.

CROmed has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available